Options Brief: Myriad Genetics

Shares of Myriad Genetics MYGN are lower on the session by 0.54%, trading at $21.21. Overall call volume is now running at 5.11x the daily average, with 36% of all calls traded being purchases on the offer. 1,420 contracts have traded on the session so far. Myriad Genetics, Inc. is a molecular diagnostic company focused on developing and marketing novel predictive medicine, personalized medicine and prognostic medicine products.